BioMarin shares up 30% on treatment result By: MarketWatch November 05, 2012 at 12:36 PM EST Shares of biotechnology company BioMarin climb more than 30% after positive results from treatment for rare disorder Read More >> Related Stocks: Biomarin Pharmaceuticals Humana Macy's